Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Albain, K. S.
Right arrow Articles by Gandara, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Albain, K. S.
Right arrow Articles by Gandara, D. R.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Journal of Clinical Oncology, Vol 13, 1880-1892, Copyright © 1995 by American Society of Clinical Oncology

ARTICLES

Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805

KS Albain, VW Rusch, JJ Crowley, TW Rice, AT Turrisi 3rd, JK Weick, VA Lonchyna, CA Presant, RJ McKenna and DR Gandara
Loyola University Medical Center, Maywood, IL, USA.

PURPOSE: To assess the feasibility of concurrent chemotherapy and irradiation (chemoRT) followed by surgery in locally advanced non-small- cell lung cancer (NSCLC) in a cooperative group setting, and to estimate response, resection rates, relapse patterns, and survival for stage subsets IIIA(N2) versus IIIB. PATIENTS AND METHODS: Biopsy proof of either positive N2 nodes (IIIAN2) or of N3 nodes or T4 primary lesions (IIIB) was required. Induction was two cycles of cisplatin and etoposide plus concurrent chest RT to 45 Gy. Resection was attempted if response or stable disease occurred. A chemoRT boost was given if either unresectable disease or positive margins or nodes was found. RESULTS: The median follow-up time for 126 eligible patients [75 stage IIIA(N2) and 51 IIIB] was 2.4 years. The objective response rate to induction was 59%, and 29% were stable. Resectability was 85% for the IIIA(N2) group eligible for surgery and 80% for the IIIB group. Reversible grade 4 toxicity occurred in 13% of patients. There were 13 treatment-related deaths (10%) and 19 others (15%) died of causes not related to toxicity or tumor. Of 65 relapses, 11% were only locoregional and 61% were only distant. There were 26 brain relapses, of which 19 were the sole site or cause of death. There was no survival difference (P = .81) between stage IIIA(N2) versus stage IIIB (median survivals, 13 and 17 months; 2-year survival rates, 37% and 39%; 3-year survival rates, 27% and 24%). The strongest predictor of long-term survival after thoracotomy was absence of tumor in the mediastinal nodes at surgery (median survivals, 30 v 10 months; 3-year survival rates, 44% v 18%; P = .0005). CONCLUSION: This trimodality approach was feasible in this Southwest Oncology Group (SWOG) study, with an encouraging 26% 3-year survival rate. An Intergroup study is currently being conducted to determine whether surgery adds more to the risk or to the benefit of chemoRT.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 J. Thorac. Cardiovasc. Surg.Home page
G. B. Ratto, R. Costa, P. Maineri, A. Alloisio, P. Bruzzi, and B. Dozin
Is there a subset of patients with preoperatively diagnosed N2 non-small cell lung cancer who might benefit from surgical resection?
J. Thorac. Cardiovasc. Surg., October 1, 2009; 138(4): 849 - 858.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
T. A. d'Amato, A. S. Ashrafi, M. J. Schuchert, D. S.A. Alshehab, A. J.E. Seely, F. M. Shamji, D. E. Maziak, S. R. Sundaresan, P. F. Ferson, J. D. Luketich, et al.
Risk of pneumonectomy after induction therapy for locally advanced non-small cell lung cancer.
Ann. Thorac. Surg., October 1, 2009; 88(4): 1079 - 1085.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
H. A. Gaissert, D. Y. Keum, C. D. Wright, M. Ancukiewicz, E. Monroe, D. M. Donahue, J. C. Wain, M. Lanuti, J. S. Allan, N. C. Choi, et al.
POINT: Operative risk of pneumonectomy--influence of preoperative induction therapy.
J. Thorac. Cardiovasc. Surg., August 1, 2009; 138(2): 289 - 294.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
V. Steger, T. Walles, B. Kosan, T. Walker, T. Kyriss, S. Veit, J. Dippon, and G. Friedel
Trimodal Therapy for Histologically Proven N2/3 Non-Small Cell Lung Cancer: Mid-Term Results and Indicators for Survival.
Ann. Thorac. Surg., June 1, 2009; 87(6): 1676 - 1683.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
W. A. Weber
Assessing Tumor Response to Therapy
J. Nucl. Med., May 1, 2009; 50(Suppl_1): 1S - 10S.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
R. J. Cerfolio, A. S. Bryant, V. L. Jones, and R. M. Cerfolio
Pulmonary resection after concurrent chemotherapy and high dose (60 Gy) radiation for non-small cell lung cancer is safe and may provide increased survival
Eur. J. Cardiothorac. Surg., April 1, 2009; 35(4): 718 - 723.
[Abstract] [Full Text] [PDF]

Home page
 Am Soc Clin Oncol Ed BookHome page
W. A. Weber
The Use of Positron Emission Tomography versus Computerized Tomography Scans in the Assessment of Response to Therapy
ASCO Educational Book, January 1, 2009; 2009(1): 474 - 478.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
J. E. Bauman, M. S. Mulligan, R. G. Martins, B. F. Kurland, K. D. Eaton, and D. E. Wood
Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes
Ann. Thorac. Surg., November 1, 2008; 86(5): 1632 - 1639.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
M. J. Edelman, M. Suntharalingam, W. Burrows, K. F. Kwong, N. Mitra, Z. Gamliel, M. Riley, L. B. Cooper, N. L. Kennedy, S. Buskirk, et al.
Phase I/II Trial of Hyperfractionated Radiation and Chemotherapy Followed by Surgery in Stage III Lung Cancer
Ann. Thorac. Surg., September 1, 2008; 86(3): 903 - 910.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
R. Bordoni
Consensus Conference: Multimodality Management of Early- and Intermediate-Stage Non-Small Cell Lung Cancer
Oncologist, September 1, 2008; 13(9): 945 - 953.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
T. Gudbjartsson, E. Gyllstedt, A. Pikwer, and P. Jonsson
Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy
Ann. Thorac. Surg., August 1, 2008; 86(2): 376 - 382.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
N. Pourel, N. Santelmo, N. Naafa, A. Serre, W. Hilgers, L. Mineur, N. Molinari, and F. Reboul
Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response
Eur. J. Cardiothorac. Surg., May 1, 2008; 33(5): 829 - 836.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
A. Marra, L. Hillejan, S. Fechner, and G. Stamatis
Remediastinoscopy in restaging of lung cancer after induction therapy.
J. Thorac. Cardiovasc. Surg., April 1, 2008; 135(4): 843 - 849.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
H. Kunitoh, H. Kato, M. Tsuboi, T. Shibata, H. Asamura, Y. Ichonose, N. Katakami, K. Nagai, T. Mitsudomi, A. Matsumura, et al.
Phase II Trial of Preoperative Chemoradiotherapy Followed by Surgical Resection in Patients With Superior Sulcus Non-Small-Cell Lung Cancers: Report of Japan Clinical Oncology Group Trial 9806
J. Clin. Oncol., February 1, 2008; 26(4): 644 - 649.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
J. Huang, G. J. Riely, K. E. Rosenzweig, and V. W. Rusch
Multimodality Therapy for Locally Advanced Thymomas: State of the Art or Investigational Therapy?
Ann. Thorac. Surg., February 1, 2008; 85(2): 365 - 367.
[Full Text] [PDF]

Home page
 JCOHome page
C. Pottgen, W. Eberhardt, A. Grannass, S. Korfee, G. Stuben, H. Teschler, G. Stamatis, H. Wagner, B. Passlick, V. Petersen, et al.
Prophylactic Cranial Irradiation in Operable Stage IIIA Non Small-Cell Lung Cancer Treated With Neoadjuvant Chemoradiotherapy: Results From a German Multicenter Randomized Trial
J. Clin. Oncol., November 1, 2007; 25(31): 4987 - 4992.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
P. Garrido, J. L. Gonzalez-Larriba, A. Insa, M. Provencio, A. Torres, D. Isla, J. M. Sanchez, F. Cardenal, M. Domine, J. R. Barcelo, et al.
Long-Term Survival Associated With Complete Resection After Induction Chemotherapy in Stage IIIA (N2) and IIIB (T4N0-1) Non Small-Cell Lung Cancer Patients: The Spanish Lung Cancer Group Trial 9901
J. Clin. Oncol., October 20, 2007; 25(30): 4736 - 4742.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
L. A. Robinson, J. C. Ruckdeschel, H. Wagner Jr, and C. W. Stevens
Treatment of Non-small Cell Lung Cancer-Stage IIIA: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition)
Chest, September 1, 2007; 132(3_suppl): 243S - 265S.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
J. R. Jett, S. E. Schild, R. L. Keith, and K. A. Kesler
Treatment of Non-small Cell Lung Cancer, Stage IIIB: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition)
Chest, September 1, 2007; 132(3_suppl): 266S - 276S.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
H. Yokomise, M. Gotoh, T. Okamoto, Y. Yamamoto, S. Ishikawa, T. Nakashima, D. Masuya, D. Liu, and C.-l. Huang
Induction chemoradiotherapy (carboplatin-taxane and concurrent 50-Gy radiation) for bulky cN2, N3 non small cell lung cancer
J. Thorac. Cardiovasc. Surg., May 1, 2007; 133(5): 1179 - 1185.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
J. P. van Meerbeeck, G. W. P. M. Kramer, P. E. Y. Van Schil, C. Legrand, E. F. Smit, F. Schramel, V. C. Tjan-Heijnen, B. Biesma, C. Debruyne, N. van Zandwijk, et al.
Randomized Controlled Trial of Resection Versus Radiotherapy After Induction Chemotherapy in Stage IIIA-N2 Non-Small-Cell Lung Cancer
J Natl Cancer Inst, March 21, 2007; 99(6): 442 - 450.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
V. W. Rusch, D. J. Giroux, M. J. Kraut, J. Crowley, M. Hazuka, T. Winton, D. H. Johnson, L. Shulman, F. Shepherd, C. Deschamps, et al.
Induction Chemoradiation and Surgical Resection for Superior Sulcus Non-Small-Cell Lung Carcinomas: Long-Term Results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160)
J. Clin. Oncol., January 20, 2007; 25(3): 313 - 318.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
R. J. Cerfolio, A. S. Bryant, E. Scott, M. Sharma, F. Robert, S. A. Spencer, and R. I. Garver
Women With Pathologic Stage I, II, and III Non-small Cell Lung Cancer Have Better Survival Than Men
Chest, December 1, 2006; 130(6): 1796 - 1802.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
B. D.T. Daly, H. C. Fernando, A. Ketchedjian, T. A. DiPetrillo, L. A. Kachnic, D. M. Morelli, and R. J. Shemin
Pneumonectomy after high-dose radiation and concurrent chemotherapy for nonsmall cell lung cancer.
Ann. Thorac. Surg., July 1, 2006; 82(1): 227 - 231.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
S.-i. Takeda, Y. Funakoshi, Y. Kadota, M. Koma, H. Maeda, S. Kawamura, and Y. Matsubara
Fall in diffusing capacity associated with induction therapy for lung cancer: a predictor of postoperative complication?
Ann. Thorac. Surg., July 1, 2006; 82(1): 232 - 236.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
S.-i. Takeda, H. Maeda, T. Okada, T. Yamaguchi, M. Nakagawa, S. Yokota, N. Sawabata, and M. Ohta
Results of pulmonary resection following neoadjuvant therapy for locally advanced (IIIA-IIIB) lung cancer.
Eur. J. Cardiothorac. Surg., July 1, 2006; 30(1): 184 - 189.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
T. E. Stinchcombe, D. Fried, D. E. Morris, and M. A. Socinski
Combined Modality Therapy for Stage III Non-Small Cell Lung Cancer
Oncologist, July 1, 2006; 11(7): 809 - 823.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
S. Fujita, N. Katakami, Y. Takahashi, K. Hirokawa, A. Ikeda, C. Tabata, T. Mio, and M. Mishima
Postoperative complications after induction chemoradiotherapy in patients with non-small-cell lung cancer.
Eur. J. Cardiothorac. Surg., June 1, 2006; 29(6): 896 - 901.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
D. Galetta, A. Cesario, S. Margaritora, V. Porziella, A. Piraino, R. M. D'Angelillo, M. A. Gambacorta, S. Ramella, L. Trodella, S. Valente, et al.
Multimodality treatment of unresectable stage III non-small cell lung cancer: Interim analysis of a phase II trial with preoperative gemcitabine and concurrent radiotherapy
J. Thorac. Cardiovasc. Surg., February 1, 2006; 131(2): 314 - 321.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
C. Pottgen, S. Levegrun, D. Theegarten, S. Marnitz, S. Grehl, R. Pink, W. Eberhardt, G. Stamatis, T. Gauler, G. Antoch, et al.
Value of 18F-Fluoro-2-Deoxy-D-Glucose-Positron Emission Tomography/Computed Tomography in Non-Small-Cell Lung Cancer for Prediction of Pathologic Response and Times to Relapse after Neoadjuvant Chemoradiotherapy
Clin. Cancer Res., January 1, 2006; 12(1): 97 - 106.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
N. Ramnath, E. Sommers, L. Robinson, C. Nwogu, A. Sharma, A. Cantor, and G. Bepler
Phase II Study of Neoadjuvant Chemotherapy With Gemcitabine and Vinorelbine in Resectable Non-small Cell Lung Cancer
Chest, November 1, 2005; 128(5): 3467 - 3474.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
Y. Matsubara, S.-i. Takeda, and T. Mashimo
Risk Stratification for Lung Cancer Surgery: Impact of Induction Therapy and Extended Resection
Chest, November 1, 2005; 128(5): 3519 - 3525.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
F. Barlesi, C. Doddoli, J.-P. Torre, R. Giudicelli, P. Fuentes, P. Thomas, and P. Astoul
Comparative prognostic features of stage IIIAN2 and IIIB non-small-cell lung cancer patients treated with surgery after induction therapy
Eur. J. Cardiothorac. Surg., October 1, 2005; 28(4): 629 - 634.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
R. J. Cerfolio, A. S. Bryant, S. A. Spencer, and A. A. Bartolucci
Pulmonary Resection After High-Dose and Low-Dose Chest Irradiation
Ann. Thorac. Surg., October 1, 2005; 80(4): 1224 - 1230.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
L. Thomas, L. A. Doyle, and M. J. Edelman
Lung Cancer in Women: Emerging Differences in Epidemiology, Biology, and Therapy
Chest, July 1, 2005; 128(1): 370 - 381.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. M. DeCamp Jr., S. Ashiku, and R. Thurer
The Role of Surgery in N2 Non-Small Cell Lung Cancer
Clin. Cancer Res., July 1, 2005; 11(13): 5033s - 5037s.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
E. E. Vokes, J. Crawford, J. Bogart, M. A. Socinski, G. Clamon, and M. R. Green
Concurrent Chemoradiotherapy for Unresectable Stage III Non-Small Cell Lung Cancer
Clin. Cancer Res., July 1, 2005; 11(13): 5045s - 5050s.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
K. F. Kwong, M. J. Edelman, M. Suntharalingam, L. B. Cooper, Z. Gamliel, W. Burrows, P. Hausner, L. A. Doyle, and M. J. Krasna
High-dose radiotherapy in trimodality treatment of Pancoast tumors results in high pathologic complete response rates and excellent long-term survival
J. Thorac. Cardiovasc. Surg., June 1, 2005; 129(6): 1250 - 1257.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
D. Farray, N. Mirkovic, and K. S. Albain
Multimodality Therapy for Stage III Non-Small-Cell Lung Cancer
J. Clin. Oncol., May 10, 2005; 23(14): 3257 - 3269.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
L. E. Gaspar, K. Chansky, K. S. Albain, E. Vallieres, V. Rusch, J. J. Crowley, R. B. Livingston, and D. R. Gandara
Time From Treatment to Subsequent Diagnosis of Brain Metastases in Stage III Non-Small-Cell Lung Cancer: A Retrospective Review by the Southwest Oncology Group
J. Clin. Oncol., May 1, 2005; 23(13): 2955 - 2961.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
K. Ohno, T. Utsumi, Y. Sasaki, and Y. Suzuki
Videopericardioscopy Using Endothoracic Sonography for Lung Cancer Staging
Ann. Thorac. Surg., May 1, 2005; 79(5): 1780 - 1782.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
V. Patel and J. B. Shrager
Which Patients with Stage III Non-Small Cell Lung Cancer Should Undergo Surgical Resection?
Oncologist, May 1, 2005; 10(5): 335 - 344.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
M. Goldberg, D. Gupta, A. R. Sasson, B. Movsas, C. J. Langer, A. L. Hanlon, H. Wang, and W. J. Scott
The Surgical Management of Superior Sulcus Tumors: A Retrospective Review With Long-Term Follow-Up
Ann. Thorac. Surg., April 1, 2005; 79(4): 1174 - 1179.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
M. Semik, D. Riesenbeck, A. Linder, C. Schmid, P. Hoffknecht, A. Heinecke, H. H. Scheld, M. Thomas, and for The German Lung Cancer Cooperative Group
Preoperative chemotherapy with and without additional radiochemotherapy: benefit and risk for surgery of stage III non-small cell lung cancer
Eur. J. Cardiothorac. Surg., December 1, 2004; 26(6): 1205 - 1210.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
N. Lorent, P. De Leyn, Y. Lievens, E. Verbeken, K. Nackaerts, C. Dooms, D. Van Raemdonck, B. Anrys, J. Vansteenkiste, and The Leuven Lung Cancer Group
Long-term survival of surgically staged IIIA-N2 non-small-cell lung cancer treated with surgical combined modality approach: analysis of a 7-year prospective experience
Ann. Onc., November 1, 2004; 15(11): 1645 - 1653.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
S. Endo, Y. Sato, T. Hasegawa, K. Tetsuka, S. Otani, N. Saito, Y. Tezuka, and Y. Sohara
Preoperative chemotherapy increases cytokine production after lung cancer surgery
Eur. J. Cardiothorac. Surg., October 1, 2004; 26(4): 787 - 791.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
K. Suzuki, H. Asamura, S.-i. Watanabe, and R. Tsuchiya
Combined Resection of Superior Vena Cava for Lung Carcinoma: Prognostic Significance of Patterns of Superior Vena Cava Invasion
Ann. Thorac. Surg., October 1, 2004; 78(4): 1184 - 1189.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
J. R. Sonett, M. Suntharalingam, M. J. Edelman, A. B. Patel, Z. Gamliel, A. Doyle, P. Hausner, and M. Krasna
Pulmonary Resection After Curative Intent Radiotherapy (>59 Gy) and Concurrent Chemotherapy in Non-Small-Cell Lung Cancer
Ann. Thorac. Surg., October 1, 2004; 78(4): 1200 - 1205.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
J. Olak and Y. Colson
Gender differences in lung cancer: Have we really come a long way, baby?
J. Thorac. Cardiovasc. Surg., September 1, 2004; 128(3): 346 - 351.
[Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
R. M. D'Angelillo, L. Trodella, and S. Ramella
Assessing the value of neoadjuvant chemoradiotherapy and pathologic downstaging in the treatment of non-small cell lung cancer.
J. Thorac. Cardiovasc. Surg., September 1, 2004; 128(3): 489 - 490.
[Full Text] [PDF]

Home page
 NEJMHome page
T. J. Lynch, C. D. Wright, N. C. Choi, S. L. Aquino, and E. J. Mark
Case 26-2004 - A 56-Year-Old Woman with Cough and a Lung Nodule
N. Engl. J. Med., August 19, 2004; 351(8): 809 - 817.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Cesario, S. Margaritora, D. Galetta, V. Porziella, P. Granone, R. M. D'Angelillo, L. Trodella, V. Cardaci, S. Sterzi, and P. Russo
Correspondence re L. J. Wirth et al., Induction Docetaxel and Carboplatin Followed by Weekly Docetaxel and Carboplatin with Concurrent Radiotherapy, Then Surgery in Stage III Non-Small Cell Lung Cancer: a Phase I Study. Clin Cancer Res 2003;9:1698-704.
Clin. Cancer Res., April 15, 2004; 10(8): 2902 - 2903.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
L. J. Wirth, A. T. Skarin, and D. J. Sugarbaker
Reply
Clin. Cancer Res., April 15, 2004; 10(8): 2904 - 2904.
[Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
K. Ohno, T. Utsumi, Y. Sasaki, and Y. Suzuki
Re-evaluation of non-palpable scalene lymph node biopsy for the staging of non-small cell lung cancer
Eur. J. Cardiothorac. Surg., April 1, 2004; 25(4): 492 - 496.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
W. Eberhardt, M. Stuschke, and G. Stamatis
Preoperative chemoradiation approaches to locally advanced non-small-cell lung cancer: one man's pride, another man's burden?
Ann. Onc., March 1, 2004; 15(3): 365 - 367.
[Full Text] [PDF]

Home page
 Ann OncolHome page
L. Trodella, P. Granone, S. Valente, S. Margaritora, G. Macis, A. Cesario, R. M. D'Angelillo, V. Valentini, G. M. Corbo, V. Porziella, et al.
Neoadjuvant concurrent radiochemotherapy in locally advanced (IIIA-IIIB) non-small-cell lung cancer: long-term results according to downstaging
Ann. Onc., March 1, 2004; 15(3): 389 - 398.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
M. Machtay, J. H. Lee, J. P. Stevenson, J. B. Shrager, K. M. Algazy, J. Treat, and L. R. Kaiser
Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: Long-term results and associations with pathologic response
J. Thorac. Cardiovasc. Surg., January 1, 2004; 127(1): 108 - 113.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
D. Galetta, A. Cesario, S. Margaritora, V. Porziella, G. Macis, R. M. D'Angelillo, L. Trodella, S. Sterzi, and P. Granone
Enduring challenge in the treatment of nonsmall cell lung cancer with clinical stage IIIB: results of a trimodality approach
Ann. Thorac. Surg., December 1, 2003; 76(6): 1802 - 1809.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
A. N. van Geel, P. P. Jansen, R. J. van Klaveren, and J. R. M. van der Sijp
High Relapse-Free Survival After Preoperative and Intraoperative Radiotherapy and Resection for Sulcus Superior Tumors
Chest, November 1, 2003; 124(5): 1841 - 1846.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
M. M. DeCamp, T. W. Rice, D. J. Adelstein, M. A. Chidel, L. A. Rybicki, S. C. Murthy, and E. H. Blackstone
Value of accelerated multimodality therapy in stage IIIA and IIIB non-small cell lung cancer
J. Thorac. Cardiovasc. Surg., July 1, 2003; 126(1): 17 - 25.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
D. R. Gandara, K. Chansky, K. S. Albain, B. R. Leigh, L. E. Gaspar, P. N. Lara Jr, H. Burris, P. Gumerlock, J. P. Kuebler, J. D. Bearden III, et al.
Consolidation Docetaxel After Concurrent Chemoradiotherapy in Stage IIIB Non-Small-Cell Lung Cancer: Phase II Southwest Oncology Group Study S9504
J. Clin. Oncol., May 15, 2003; 21(10): 2004 - 2010.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
D. C. Betticher, S.-F. Hsu Schmitz, M. Totsch, E. Hansen, C. Joss, C. von Briel, R. A. Schmid, M. Pless, J. Habicht, A. D. Roth, et al.
Mediastinal Lymph Node Clearance After Docetaxel-Cisplatin Neoadjuvant Chemotherapy Is Prognostic of Survival in Patients With Stage IIIA pN2 Non-Small-Cell Lung Cancer: A Multicenter Phase II Trial
J. Clin. Oncol., May 1, 2003; 21(9): 1752 - 1759.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
S. S. Leong, E. H. Tan, K. W. Fong, E. Wilder-Smith, Y. K. Ong, B. C. Tai, L. Chew, S. H. Lim, J. Wee, K. M. Lee, et al.
Randomized Double-Blind Trial of Combined Modality Treatment With or Without Amifostine in Unresectable Stage III Non-Small-Cell Lung Cancer
J. Clin. Oncol., May 1, 2003; 21(9): 1767 - 1774.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
L. J. Wirth, J. Lucca, P. Ostler, P. Fidias, C. Lynch, P. A. Janne, R. S. Herbst, B. E. Johnson, D. J. Sugarbaker, D. J. Mathisen, et al.
Induction Docetaxel and Carboplatin Followed by Weekly Docetaxel and Carboplatin with Concurrent Radiotherapy, then Surgery in Stage III Non-Small Cell Lung Cancer: A Phase I Study
Clin. Cancer Res., May 1, 2003; 9(5): 1698 - 1704.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
A. Granetzny, E. Striehn, U. Bosse, W. Wagner, O. Koch, U. Vogt, P. Froeschle, and F. Klinke
A phase II single-institution study of neoadjuvant stage IIIA/B chemotherapy and radiochemotherapy in non-small cell lung cancer
Ann. Thorac. Surg., April 1, 2003; 75(4): 1107 - 1112.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
K. Nagai, R. Tsuchiya, T. Mori, H. Tada, Y. Ichinose, T. Koike, and H. Kato
A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209)
J. Thorac. Cardiovasc. Surg., February 1, 2003; 125(2): 254 - 260.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
M. Ohta, N. Sawabata, H. Maeda, and H. Matsuda
Efficacy and safety of tracheobronchoplasty after induction therapy for locally advanced lung cancer
J. Thorac. Cardiovasc. Surg., January 1, 2003; 125(1): 96 - 100.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
J. R. Jett, W. J. Scott, M. P. Rivera, and W. T. Sause
Guidelines on Treatment of Stage IIIB Non-small Cell Lung Cancer
Chest, January 1, 2003; 123 (2009): 221S - 225S.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. G. Spiro and J. C. Porter
Lung Cancer--Where Are We Today?: Current Advances in Staging and Nonsurgical Treatment
Am. J. Respir. Crit. Care Med., November 1, 2002; 166(9): 1166 - 1196.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
E. E. Vokes, J. E. Herndon II, J. Crawford, K. A. Leopold, M. C. Perry, A. A. Miller, and M. R. Green
Randomized Phase II Study of Cisplatin With Gemcitabine or Paclitaxel or Vinorelbine as Induction Chemotherapy Followed by Concomitant Chemoradiotherapy for Stage IIIB Non-Small-Cell Lung Cancer: Cancer and Leukemia Group B Study 9431
J. Clin. Oncol., October 15, 2002; 20(20): 4191 - 4198.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
F. Venuta, E. A. Rendina, T. De Giacomo, E. Mercadante, F. Francioni, F. Pugliese, M. Moretti, and G. F. Coloni
Nd:YAG laser resection of lung cancer invading the airway as a bridge to surgery and palliative treatment
Ann. Thorac. Surg., October 1, 2002; 74(4): 995 - 998.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
K. S. Albain, J. J. Crowley, A. T. Turrisi III, D. R. Gandara, W. B. Farrar, J. I. Clark, K. R. Beasley, and R. B. Livingston
Concurrent Cisplatin, Etoposide, and Chest Radiotherapy in Pathologic Stage IIIB Non-Small-Cell Lung Cancer: A Southwest Oncology Group Phase II Study, SWOG 9019
J. Clin. Oncol., August 15, 2002; 20(16): 3454 - 3460.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
A. Cyjon, M. Nili, G. Fink, M. R. Kramer, E. Fenig, J. Sandbank, A. Sulkes, and E. Rakowsky
Advanced non-small cell lung cancer: induction chemotherapy and chemoradiation before operation
Ann. Thorac. Surg., August 1, 2002; 74(2): 342 - 347.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
C. C.M. Pitz, K. W. Maas, H. A. V. Swieten, A. Brutel de la Riviere, P. Hofman, and F. M.N.H. Schramel
Surgery as part of combined modality treatment in stage IIIB non-small cell lung cancer
Ann. Thorac. Surg., July 1, 2002; 74(1): 164 - 169.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
C. D. Wright, M. T. Menard, J. C. Wain, D. M. Donahue, H. C. Grillo, T. J. Lynch, N. C. Choi, and D. J. Mathisen
Induction chemoradiation compared with induction radiation for lung cancer involving the superior sulcus
Ann. Thorac. Surg., May 1, 2002; 73(5): 1541 - 1544.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. Martin, R. J. Ginsberg, E. S. Venkatraman, M. S. Bains, R. J. Downey, R. J. Korst, M. G. Kris, and V. W. Rusch
Long-Term Results of Combined-Modality Therapy in Resectable Non-Small-Cell Lung Cancer
J. Clin. Oncol., April 15, 2002; 20(8): 1989 - 1995.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
C. Pottgen, W. Eberhardt, S. Bildat, G. Stuben, G. Stamatis, L. Hillejan, S. Sohrab, H. Teschler, S. Seeber, H. Sack, et al.
Induction chemotherapy followed by concurrent chemotherapy and definitive high-dose radiotherapy for patients with locally advanced non-small-cell lung cancer (stages IIIa/IIIb): a pilot phase I/II trial
Ann. Onc., March 1, 2002; 13(3): 403 - 411.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
D. H. Grunenwald, C. Mazel, P. Girard, G. Veronesi, L. Spaggiari, D. Gossot, D. Debrosse, R. Caliandro, J.-L. Le Guillou, and T. Le Chevalier
Radical en bloc resection for lung cancer invading the spine
J. Thorac. Cardiovasc. Surg., February 1, 2002; 123(2): 271 - 279.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
J.F. Vansteenkiste
Imaging in lung cancer: positron emission tomography scan
Eur. Respir. J., February 1, 2002; 19(35_suppl): 49S - 60s.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
L. Voltolini, L. Luzzi, C. Ghiribelli, P. Paladini, M. Di Bisceglie, and G. Gotti
Results of induction chemotherapy followed by surgical resection in patients with stage IIIA (N2) non-small cell lung cancer: the importance of the nodal down-staging after chemotherapy
Eur. J. Cardiothorac. Surg., December 1, 2001; 20(6): 1106 - 1112.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
K. Junker, K. Langner, F. Klinke, U. Bosse, and M. Thomas
Grading of Tumor Regression in Non-small Cell Lung Cancer : Morphology and Prognosis
Chest, November 1, 2001; 120(5): 1584 - 1591.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
D. H. Grunenwald, F. Andre, C. Le Pechoux, P. Girard, C. Lamer, A. Laplanche, M. Tarayre, R. Arriagada, and T. Le Chevalier
Benefit of surgery after chemoradiotherapy in stage IIIB (T4 and/or N3) non-small cell lung cancer
J. Thorac. Cardiovasc. Surg., October 1, 2001; 122(4): 796 - 802.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
J. Martin, R. J. Ginsberg, A. Abolhoda, M. S. Bains, R. J. Downey, R. J. Korst, T. L. Weigel, M. G. Kris, E. S. Venkatraman, and V. W. Rusch
Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy
Ann. Thorac. Surg., October 1, 2001; 72(4): 1149 - 1154.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
J. R. Roberts, C. Eustis, R. Devore, D. Carbone, H. Choy, and D. Johnson
Induction chemotherapy increases perioperative complications in patients undergoing resection for non-small cell lung cancer
Ann. Thorac. Surg., September 1, 2001; 72(3): 885 - 888.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
F. Venuta, E. A. Rendina, T. De Giacomo, E. Mercadante, A. M. Ciccone, M. T. Aratari, M. Moretti, and G. F. Coloni
Endoscopic treatment of lung cancer invading the airway before induction chemotherapy and surgical resection
Eur. J. Cardiothorac. Surg., September 1, 2001; 20(3): 464 - 467.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
J.F. Vansteenkiste and S.G. Stroobants
The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology
Eur. Respir. J., April 1, 2001; 17(4): 802 - 820.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
M. P. Siegenthaler, K. M. Pisters, K. W. Merriman, J. A. Roth, S. G. Swisher, G. L. Walsh, A. A. Vaporciyan, W. R. Smythe, and J. B. Putnam Jr
Preoperative chemotherapy for lung cancer does not increase surgical morbidity
Ann. Thorac. Surg., April 1, 2001; 71(4): 1105 - 1112.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
V. W. Rusch, D. J. Giroux, M. J. Kraut, J. Crowley, M. Hazuka, D. Johnson, M. Goldberg, F. Detterbeck, F. Shepherd, R. Burkes, et al.
Induction chemoradiation and surgical resection for non-small cell lung carcinomas of the superior sulcus: Initial results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160)
J. Thorac. Cardiovasc. Surg., March 1, 2001; 121(3): 472 - 483.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
F. W. Grannis Jr, F. Andre, T. Le Chevalier, and D. Grunenwald
Subclassification of N2 Non-Small-Cell Lung Cancer
J. Clin. Oncol., February 15, 2001; 19(4): 1228 - 1229.
[Full Text]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
F. Andre, D. Grunewald, and T. Le Chevalier
Persistence of viable tumor cells after radiation and chemotherapy for stage IIIB non-small cell lung cancer: An early marker of treatment failure
J. Thorac. Cardiovasc. Surg., February 1, 2001; 121(2): 403 - 403.
[Full Text] [PDF]

Home page
 The OncologistHome page
E. E. Vokes
Induction Chemotherapy Followed by Concomitant Chemoradiotherapy for Non-Small Cell Lung Cancer
Oncologist, February 1, 2001; 6(2008): 25 - 27.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. A. Hayman, M. K. Martel, R. K. Ten Haken, D. P. Normolle, R. F. Todd III, J. F. Littles, M. A. Sullivan, P. W. Possert, A. T. Turrisi, and A. S. Lichter
Dose Escalation in Non-Small-Cell Lung Cancer Using Three-Dimensional Conformal Radiation Therapy: Update of a Phase I Trial
J. Clin. Oncol., January 1, 2001; 19(1): 127 - 136.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
R. Bueno, W. G. Richards, S. J. Swanson, M. T. Jaklitsch, J. M. Lukanich, S. J. Mentzer, and D. J. Sugarbaker
Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival
Ann. Thorac. Surg., December 1, 2000; 70(6): 1826 - 1831.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
F. Andre, D. Grunenwald, J.-P. Pignon, A. Dujon, J. L. Pujol, P. Y. Brichon, L. Brouchet, E. Quoix, V. Westeel, and T. Le Chevalier
Survival of Patients With Resected N2 Non-Small-Cell Lung Cancer: Evidence for a Subclassification and Implications
J. Clin. Oncol., August 16, 2000; 18(16): 2981 - 2989.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
N. Van Zandwijk, E. F. Smit, G. W. P. Kramer, F. Schramel, S. Gans, J. Festen, A. Termeer, N. J. J. Schlosser, C. Debruyne, D. Curran, et al.
Gemcitabine and Cisplatin as Induction Regimen for Patients With Biopsy-Proven Stage IIIA N2 Non-Small-Cell Lung Cancer: A Phase II Study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955)
J. Clin. Oncol., July 14, 2000; 18(14): 2658 - 2664.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
Y. Ohta, Y. Tanaka, T. Hara, M. Oda, S.-i. Watanabe, J. Shimizu, and Y. Watanabe
Clinicopathological and biological assessment of lung cancers with pleural dissemination
Ann. Thorac. Surg., April 1, 2000; 69(4): 1025 - 1029.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
G. M. Strauss
Role of Chemotherapy in Stages I to III Non-small Cell Lung Cancer*
Chest, December 1, 1999; 116 (2009): 509S - 516S.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. Stuschke, W. Eberhardt, C. Pottgen, G. Stamatis, H. Wilke, G. Stuben, F. Stoblen, H. H. Wilhelm, H. Menker, H. Teschler, et al.
Prophylactic Cranial Irradiation in Locally Advanced Non-Small-Cell Lung Cancer After Multimodality Treatment: Long-Term Follow-Up and Investigations of Late Neuropsychologic Effects
J. Clin. Oncol., September 1, 1999; 17(9): 2700 - 2700.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
J. R. Roberts, R. Bueno, and D. J. Sugarbaker
Multimodality Treatment of Malignant Superior Vena Caval Syndrome
Chest, September 1, 1999; 116(3): 835 - 837.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
J. R. Sonett, M. J. Krasna, M. Suntharalingam, J. Schuetz, L. A. Doyle, R. Lilenbaum, and Z. Gamliel
Safe pulmonary resection after chemotherapy and high-dose thoracic radiation
Ann. Thorac. Surg., August 1, 1999; 68(2): 316 - 320.
[Abstract] [Full Text] [PDF]


About
JCO		 Editorial
Roster		 Advertising
Information		 Librarians &
Institutions		 Rights &
Permissions		 PDA Services

Copyright © 1995 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online